Tags

Type your tag names separated by a space and hit enter

Splanchnic and systemic vasodilatation: the patient.
J Clin Gastroenterol. 2007 Nov-Dec; 41 Suppl 3:S266-71.JC

Abstract

Arterial vasodilatation is one of the most important characteristics of cirrrhosis and portal hyptertension. Nowadays, it has been known that progressive vasodilatation is an essential factor contributing to hyperdynamic circulation and multiple organ dysfunction in liver cirrhosis. Over the past decades, numerous investigations have originated from the clinical observations. Clinicians and investigators have learned and applied new concepts of the pathophysiology of portal hypertension. For example, we now have effective pharmacologic treatment for hepatorenal syndrome. This review summarizes the developement of progressive vasodilatation syndrome in liver cirrhosis and portal hypertension with focus on the patients.

Authors+Show Affiliations

Tsai MH
Division of Gastroenterology, Chang Gung Memorial Hospital, Chang Gung University [corrected] Taipei, Taiwan. mhtsai@cgmh.org.tw

MeSH

ArteriesCardiac OutputCerebrovascular CirculationCoronary CirculationHepatorenal SyndromeHumansHypertension, PortalLiver CirrhosisPulmonary CirculationRenal CirculationSplanchnic CirculationVasodilation

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

17975476

Citation

Tsai, Ming-Hung. "Splanchnic and Systemic Vasodilatation: the Patient." Journal of Clinical Gastroenterology, vol. 41 Suppl 3, 2007, pp. S266-71.
Tsai MH. Splanchnic and systemic vasodilatation: the patient. J Clin Gastroenterol. 2007;41 Suppl 3:S266-71.
Tsai, M. H. (2007). Splanchnic and systemic vasodilatation: the patient. Journal of Clinical Gastroenterology, 41 Suppl 3, S266-71.
Tsai MH. Splanchnic and Systemic Vasodilatation: the Patient. J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. PubMed PMID: 17975476.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Splanchnic and systemic vasodilatation: the patient. A1 - Tsai,Ming-Hung, PY - 2007/12/6/pubmed PY - 2008/2/7/medline PY - 2007/12/6/entrez SP - S266 EP - 71 JF - Journal of clinical gastroenterology JO - J Clin Gastroenterol VL - 41 Suppl 3 N2 - Arterial vasodilatation is one of the most important characteristics of cirrrhosis and portal hyptertension. Nowadays, it has been known that progressive vasodilatation is an essential factor contributing to hyperdynamic circulation and multiple organ dysfunction in liver cirrhosis. Over the past decades, numerous investigations have originated from the clinical observations. Clinicians and investigators have learned and applied new concepts of the pathophysiology of portal hypertension. For example, we now have effective pharmacologic treatment for hepatorenal syndrome. This review summarizes the developement of progressive vasodilatation syndrome in liver cirrhosis and portal hypertension with focus on the patients. SN - 0192-0790 UR - https://www.unboundmedicine.com/medline/citation/17975476/Splanchnic_and_systemic_vasodilatation:_the_patient_ DB - PRIME DP - Unbound Medicine ER -